Anti-biofilm properties of the antimicrobial peptide temporin 1Tb and its ability, in combination with EDTA, to eradicate Staphylococcus epidermidis biofilms on silicone catheters

References

• Banin E, Brady KM, Greenberg EP. 2006. Chelator-induced dispersal and killing of Pseudomonas aeruginosa cells in a biofilm. Appl Environ Microbiol. 72:2064–2069. doi:10.1128/AEM.72.3.2064-2069.2006
   PubMed Web of Science ®Google Scholar
• Batoni G, Maisetta G, Esin S. 2016. Antimicrobial peptides and their interaction with biofilms of medically relevant bacteria. Biochim Biophys Acta. 1858:1044–1060. doi:10.1016/j.bbamem.2015.10.013
   PubMed Web of Science ®Google Scholar
• Beloin C, Renard S, Ghigo JM, Lebeaux D. 2014. Novel approaches to combat bacterial biofilms. Curr Opin Pharmacol. 18:61–68. doi:10.1016/j.coph.2014.09.005
   PubMed Web of Science ®Google Scholar
• Brackman G, Coenye T. 2015. Quorum sensing inhibitors as anti-biofilm agents. Curr Pharm Des. 21:5–11. doi:10.2174/1381612820666140905114627
   PubMed Web of Science ®Google Scholar
• Brancatisano FL, Maisetta G, Di Luca M, Esin S, Bottai D, Bizzarri R, Campa M, Batoni G. 2014. Inhibitory effect of the human liver-derived antimicrobial peptide hepcidin 20 on biofilms of polysaccharide intercellular adhesin (PIA)-positive and PIA-negative strains of Staphylococcus epidermidis. Biofouling. 30:435–446. doi:10.1080/08927014.2014.888062
   PubMed Web of Science ®Google Scholar
• Chaignon P, Sadovskaya I, Ragunah Ch, Ramasubbu N, Kaplan JB, Jabbouri S. 2007. Susceptibility of staphylococcal biofilms to enzymatic treatments depends on their chemical composition. Appl Microbiol Biotechnol. 75:125–132. doi:10.1007/s00253-006-0790-y
   PubMed Web of Science ®Google Scholar
• Chauhan A, Lebeaux D, Ghigo JM, Beloin C. 2012. Full and broad-spectrum in vivo eradication of catheter-associated biofilms using gentamicin-EDTA antibiotic lock therapy. Antimicrob Agents Chemother. 56:6310–6318. doi:10.1128/AAC.01606-12
   PubMed Web of Science ®Google Scholar
• Di Grazia A, Luca V, Segev-Zarko LA, Shai Y, Mangoni ML. 2014. Temporins A and B stimulate migration of HaCaT keratinocytes and kill intracellular Staphylococcus aureus. Antimicrob Agents Chemother. 58:2520–2527. doi:10.1128/AAC.02801-13
   PubMed Web of Science ®Google Scholar
• Di Luca M, Maccari G, Maisetta G, Batoni G. 2015. BaAMPs: the database of biofilm-active antimicrobial peptides. Biofouling. 31:193–199. doi:10.1080/08927014.2015.1021340
   PubMed Web of Science ®Google Scholar
• Donelli G, Francolini I, Romoli D, Guaglianone E, Piozzi A, Ragunath C, Kaplan JB. 2007. Synergistic activity of dispersin B and cefamandole nafate in inhibition of staphylococcal biofilm growth on polyurethanes. Antimicrob Agents Chemother. 51:2733–2740. doi:10.1128/AAC.01249-06
   PubMed Web of Science ®Google Scholar
• Fey PD, Olson ME. 2010. Current concepts in biofilm formation of Staphylococcus epidermidis. Future Microbiol. 5:917–933. doi:10.2217/fmb.10.56
   PubMed Web of Science ®Google Scholar
• Fortún J, Grill F, Martín-Dávila P, Blázquez J, Tato M, Sánchez-Corral J, García-San Miguel L, Moreno S. 2006. Treatment of long-term intravascular catheter-related bacteraemia with antibiotic-lock therapy. J Antimicrob Chemother. 58:816–821. doi:10.1093/jac/dkl318
   PubMed Web of Science ®Google Scholar
• Gomes F, Teixeira P, Oliveira R. 2014. Mini-review: Staphylococcus epidermidis as the most frequent cause of nosocomial infections: old and new fighting strategies. Biofouling. 30:131–141. doi:10.1080/08927014.2013.848858
   PubMed Web of Science ®Google Scholar
• Høiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O. 2010. Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents. 35:322–332. doi:10.1016/j.ijantimicag.2009.12.011
   PubMed Web of Science ®Google Scholar
• Justo JA, Bookstaver PB. 2014. Antibiotic lock therapy: review of technique and logistical challenges. Infect Drug Resist. 7:343–363. doi:10.2147/IDR.S51388
   PubMed Web of Science ®Google Scholar
• Kaplan JB, LoVetri K, Cardona ST, Madhyastha S, Sadovskaya I, Jabbouri S, Izano EA. 2012. Recombinant human DNase I decreases biofilm and increases antimicrobial susceptibility in staphylococci. J Antibiot (Tokyo). 65:73–77. doi:10.1038/ja.2011.113
   PubMed Web of Science ®Google Scholar
• Kite P, Eastwood K, Sugden S, Percival SL. 2004. Use of in vivo-generated biofilms from hemodialysis catheters to test the efficacy of a novel antimicrobial catheter lock for biofilm eradication in vitro. J Clin Microbiol. 42:3073–3076. doi:10.1128/JCM.42.7.3073-3076.2004
   PubMed Web of Science ®Google Scholar
• Kogan G, Sadovskaya I, Chaignon P, Chokr A, Jabbouri S. 2006. Biofilms of clinical strains of Staphylococcus that do not contain polysaccharide intercellular adhesin. FEMS Microbiol Lett. 255:11–16. doi:10.1111/j.1574-6968.2005.00043.x
   PubMed Web of Science ®Google Scholar
• Lebeaux D, Leflon-Guibout V, Ghigo JM, Beloin C. 2015. In vitro activity of gentamicin, vancomycin or amikacin combined with EDTA or l-arginine as lock therapy against a wide spectrum of biofilm-forming clinical strains isolated from catheter-related infections. J Antimicrob Chemother. 70:1704–1712. doi:10.1093/jac/dkv044
   PubMed Web of Science ®Google Scholar
• Maisetta G, Mangoni ML, Esin S, Pichierri G, Capria AL, Brancatisano FL, Di Luca M, Barnini S, Barra D, Campa M, et al. 2009. In vitro bactericidal activity of the N-terminal fragment of the frog peptide esculentin-1b (Esc 1–18) in combination with conventional antibiotics against Stenotrophomonas maltophilia. Peptides. 30:1622–1626. doi:10.1016/j.peptides.2009.06.004
   PubMed Web of Science ®Google Scholar
• Mangoni ML. 2006. Temporins, anti-infective peptides with expanding properties. Cell Mol Life Sci. 63:1060–1069. doi:10.1007/s00018-005-5536-y
   PubMed Web of Science ®Google Scholar
• Mangoni ML, Grazia AD, Cappiello F, Casciaro B, Luca V. 2016. Naturally occurring peptides from Rana temporaria: antimicrobial properties and more. Curr Top Med Chem. 16:54–64.
   PubMed Web of Science ®Google Scholar
• Mangoni ML, Maisetta G, Di Luca M, Gaddi LM, Esin S, Florio W, Brancatisano FL, Barra D, Campa M, Batoni G. 2008. Comparative analysis of the bactericidal activities of amphibian peptide analogues against multidrug-resistant nosocomial bacterial strains. Antimicrob Agents Chemother. 52:85–91. doi:10.1128/AAC.00796-07
   PubMed Web of Science ®Google Scholar
• Mataraci E, Dosler S. 2012. In vitro activities of antibiotics and antimicrobial cationic peptides alone and in combination against methicillin-resistant Staphylococcus aureus biofilms. Antimicrob Agents Chemother. 56:6366–6371. doi:10.1128/AAC.01180-12
   PubMed Web of Science ®Google Scholar
• McIntyre CW, Hulme LJ, Taal M, Fluck RJ. 2004. Locking of tunneled hemodialysis catheters with gentamicin and heparin. Kidney Int. 66:801–805. doi:10.1111/j.1523-1755.2004.00806.x
   PubMed Web of Science ®Google Scholar
• Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O’Grady NP, Raad II, Rijnders BJ, Sherertz RJ, Warren DK. 2009. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis. 49:1–45. doi:10.1086/599376
   PubMed Web of Science ®Google Scholar
• Park SC, Park Y, Hahm KS. 2011. The role of antimicrobial peptides in preventing multidrug-resistant bacterial infections and biofilm formation. Int J Mol Sci. 12:5971–5992. doi:10.3390/ijms12095971
   PubMed Web of Science ®Google Scholar
• Percival SL, Kite P, Eastwood K, Murga R, Carr J, Arduino MJ, Donlan RM. 2005. Tetrasodium EDTA as a novel central venous catheter lock solution against biofilm. Infect Control Hosp Epidemiol. 26:515–519. doi:10.1086/502577
   PubMed Web of Science ®Google Scholar
• Piras AM, Maisetta G, Sandreschi S, Gazzarri M, Bartoli C, Grassi L, Esin S, Chiellini F, Batoni G. 2015. Chitosan nanoparticles loaded with the antimicrobial peptide temporin B exert a long-term antibacterial activity in vitro against clinical isolates of Staphylococcus epidermidis. Front Microbiol. 6:372. doi:10.3389/fmicb.2015.00372
   PubMed Web of Science ®Google Scholar
• Raad I, Alrahwan A, Rolston K. 1998. Staphylococcus epidermidis: emerging resistance and need for alternative agents. Clin Infect Dis. 26:1182–1187. doi:10.1086/520285
   PubMed Web of Science ®Google Scholar
• Raad I, Chatzinikolaou I, Chaiban G, Hanna H, Hachem R, Dvorak T, Cook G, Costerton W. 2003. In vitro and ex vivo activities of minocycline and EDTA against microorganisms embedded in biofilm on catheter surfaces. Antimicrob Agents Chemother. 47:3580–3585. doi:10.1128/AAC.47.11.3580-3585.2003
   PubMed Web of Science ®Google Scholar
• Rinaldi AC, Di Giulio A, Liberi M, Gualtieri G, Oratore A, Bozzi A, Schininà ME, Simmaco M. 2001. Effects of temporins on molecular dynamics and membrane permeabilization in lipid vesicles. J Pept Res. 58:213–220. doi:10.1034/j.1399-3011.2001.00896.x
   PubMedGoogle Scholar
• Segev-Zarko L, Saar-Dover R, Brumfeld V, Mangoni ML, Shai Y. 2015. Mechanisms of biofilm inhibition and degradation by antimicrobial peptides. Biochem J. 468:259–270. doi:10.1042/BJ20141251
   PubMed Web of Science ®Google Scholar
• Shanks RM, Sargent JL, Martinez RM, Graber ML, O’Toole GA. 2006. Catheter lock solutions influence staphylococcal biofilm formation on abiotic surfaces. Nephrol Dial Transplant. 21:2247–2255. doi:10.1093/ndt/gfl170
   PubMed Web of Science ®Google Scholar
• Sousa C, Henriques M, Oliveira R. 2011. Mini-review: Antimicrobial central venous catheters–recent advances and strategies. Biofouling. 27:609–620. doi:10.1080/08927014.2011.593261
   PubMedGoogle Scholar
• Spiliopoulou AI, Krevvata MI, Kolonitsiou F, Harris LG, Wilkinson TS, Davies AP, Dimitracopoulos GO, Karamanos NK, Mack D, Anastassiou ED. 2012. An extracellular Staphylococcus epidermidis polysaccharide: relation to polysaccharide intercellular adhesin and its implication in phagocytosis. BMC Microbiol. 12:76. doi:10.1186/1471-2180-12-76
   PubMed Web of Science ®Google Scholar
• Strempel N, Strehmel J, Overhage J. 2015. Potential application of antimicrobial peptides in the treatment of bacterial biofilm infections. Curr Pharm Des. 21:67–84. doi:10.2174/1381612820666140905124312
   PubMed Web of Science ®Google Scholar
• Wu X, Wang Y, Tao L. 2011. Sulfhydryl compounds reduce Staphylococcus aureus biofilm formation by inhibiting PIA biosynthesis. FEMS Microbiol Lett. 316:44–50. doi:10.1111/j.1574-6968.2010.02190.x
   PubMed Web of Science ®Google Scholar
• Yousif A, Jamal MA, Raad I. 2015. Biofilm-based central line-associated bloodstream infections. Adv Exp Med Biol. 830:157–179. doi:10.1007/978-3-319-11038-7_10
   PubMed Web of Science ®Google Scholar